Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
8.81
+0.07 (0.80%)
At close: Aug 1, 2025, 4:00 PM
8.84
+0.03 (0.34%)
After-hours: Aug 1, 2025, 7:56 PM EDT
Splunk Market Cap
Viatris has a market cap or net worth of $10.34 billion as of August 1, 2025. Its market cap has decreased by -26.65% in one year.
Market Cap
10.34B
Enterprise Value
23.80B
1-Year Change
-26.65%
Ranking
Category
Stock Price
$8.81
Market Cap Chart
Since May 15, 1984, Viatris's market cap has increased from $146.99M to $10.34B, an increase of 6,934.67%. That is a compound annual growth rate of 10.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 10.34B | -30.42% |
| Dec 31, 2024 | 14.86B | 14.38% |
| Dec 29, 2023 | 12.99B | -3.74% |
| Dec 30, 2022 | 13.50B | -17.51% |
| Dec 31, 2021 | 16.36B | -27.24% |
| Dec 31, 2020 | 22.49B | 116.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |